ArticleBiochemical and biophysical research communications2017

Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma.

Miki Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.